Biodexa Pharmaceuticals Plc carries a market capitalization of 291,432.00, placing it among publicly traded companies globally.
| Market Cap | 291,432.00 |
| Enterprise Value | N/A |
Biodexa Pharmaceuticals Plc's stock has declined approximately -98.95979% over the past 52 weeks. The 50-day moving average sits at 0.88, while the 200-day moving average is 3.68.
| Beta (5Y) | N/A |
| 52-Week Price Change | -98.95979% |
| 50-Day Moving Average | 0.88 |
| 200-Day Moving Average | 3.68 |
| Average Volume (20 Days) | N/A |
Biodexa Pharmaceuticals Plc's most recent stock split took place on October 26, 2026 with a 8:1 split ratio.
| Last Split Date | 10/26/2026 |
| Split Ratio | 8:1 |
Already premium? Sign in